NEWS
St. Jude, Washington University Launch Genome Project for Childhood Cancers
Researchers at St. Jude Children's Research Hospital and the Washington University School of Medicine in St. Louis have launched the Pediatric Cancer Genome Project to sequence the genomes of at least 600 children with cancer over the next 3 years. The collaboration marks the first time that whole-genome sequencing will be used on a large scale to discover genetic changes driving pediatric cancers. Read more > >
Adjuvant Chemotherapy May Benefit Older Patients with Colorectal Cancer
Patients age 70 or older saw improved disease-free survival with newer treatment regimenBrain Cancer, Like Other Cancers, Has Distinct Subtypes
Patients with different forms of glioblastoma had varying responses to treatmentStrategy May Enhance Umbilical Cord Blood Transplants
Technique could speed the restoration of immune cells after chemotherapyAcupuncture Reduces Joint Pain in Some Women with Breast Cancer
The benefit was seen in postmenopausal women taking aromatase inhibitorsGenome Scans for Pancreatic Cancer Yield Clues to Risk
A large genome-wide association study points to new chromosome regions
COMMENTARY
Guest Director's Update: Major Grant Application Changes Now in Effect
by Dr. Paulette Gray
The new year is beginning with a very important change for investigators intending to apply for grant dollars from NIH to support their research. As of January 25, the NIH grants application process will undergo the most significant changes to date with newly restructured and shortened application forms. Read more > >
A Conversation about Sequencing Cancer Genomes with Dr. Elaine Mardis
The co-director of the Genome Center at the Washington University School of Medicine in St. Louis discusses the cost, benefits, and technical challenges of sequencing cancer genomes. Read more > >
| Subscribe Now! | ||
IN DEPTH
Trials Point to Potential Advances in Lung Cancer Treatment
Investigational drugs may offer options for more personalized therapy
Helping Breast Cancer Gene Mutation Carriers Weigh Prevention Choices
Risk modeling may help women with BRCA mutations choose risk-reducing and surveillance strategies
The Downside of Diagnostic Imaging
Recent studies clarify cancer risks from computed tomography and nuclear imaging
Featured Clinical Trial: Adjuvant Bevacizumab and Chemotherapy for High-risk Breast Cancer
Can bevacizumab help prevent recurrence of high-risk breast cancer?
Chinese and American Scientists Meet to Discuss Environmental Causes of Cancer
Talks focused on adult lung and childhood cancers
UPDATES
Cancer.gov Update
- Recovery Web Site Highlights the NCI Community Cancer Centers Program
- NCI Launches Web Site for the Alliance of Glycobiologists
- Online Resource on Menthol and Tobacco Now Available from NCI
- NCI's Reagents Data Portal Features Added Content
Notes
- NCRR Hosts CTSA Industry Forum to Promote Collaboration, Drug Development
- Registration Open for Cancer Drug Development Meeting
- NCI Holds Annual Intramural Scientific Retreat
- New NCI Spanish-language Resources Available
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
